
News|Articles|June 1, 2004
ACE inhibitor delays prevalence of WML in stroke victims
Perindopril, an angiotensin-converting enzyme (ACE) inhibitor, can help stop or delay the progress of white matter lesions (WML) in patients with prior cerebrovascular disease, according to research presented at the annual meeting of the American Academy of Neurology.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Whole Health and Pharmacy: The Overlooked Alliance in Chronic Disease Management
2
Almost Half of Severe Alopecia Areata Pediatric Patients Saw Hair Regrowth on Olumiant, Study Shows | 2025 Fall Clinical Derm
3
Beyond Sotyktu: Next-Gen TYK2 Drugs Enter Late-Stage Development | Fall Clinical Derm 2025
4
Discussing Innovative Research in Vitiligo
5


















































